DZ Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.16M Buy
109,031
+29,172
+37% +$1.7M 0.01% 468
2025
Q4
$4.75M Buy
79,859
+9,223
+13% +$502K ﹤0.01% 518
2025
Q3
$3.83M Buy
70,636
+42,966
+155% +$2.46M ﹤0.01% 548
2025
Q2
$1.52M Sell
27,670
-22,621
-45% -$1.33M ﹤0.01% 629
2025
Q1
$3.56M Buy
50,291
+13,494
+37% +$908K ﹤0.01% 499
2024
Q4
$2.42M Sell
36,797
-20,689
-36% -$1.39M ﹤0.01% 535
2024
Q3
$4.04M Buy
57,486
+41,845
+268% +$3.5M ﹤0.01% 495
2024
Q2
$1.29M Sell
15,641
-121,348
-89% -$10.1M ﹤0.01% 637
2024
Q1
$12M Buy
136,989
+7,023
+5% +$629K 0.01% 323
2023
Q4
$12.5M Sell
129,966
-21,421
-14% -$1.9M 0.02% 321
2023
Q3
$13.4M Buy
151,387
+56,011
+59% +$4.98M 0.02% 298
2023
Q2
$8.27M Sell
95,376
-37,398
-28% -$3.52M 0.01% 382
2023
Q1
$12.9M Sell
132,774
-75,292
-36% -$7.81M 0.02% 306
2022
Q4
$21.5M Buy
208,066
+14,281
+7% +$1.34M 0.04% 239
2022
Q3
$16.4M Buy
193,785
+40,806
+27% +$3.63M 0.03% 247
2022
Q2
$12.7M Buy
152,979
+28,323
+23% +$2.26M 0.02% 283
2022
Q1
$9.61M Buy
124,656
+6,914
+6% +$579K 0.01% 372
2021
Q4
$10.5M Sell
117,742
-2,969
-2% -$245K 0.02% 363
2021
Q3
$9.33M Buy
120,711
+13,319
+12% +$1.05M 0.02% 382
2021
Q2
$8.96M Buy
107,392
+42,538
+66% +$3.37M 0.01% 400
2021
Q1
$4.9M Hold
64,854
0.01% 457
2020
Q4
$5.65M Buy
64,854
+24,854
+62% +$1.97M 0.01% 404
2020
Q3
$3.04M Hold
40,000
0.01% 430
2020
Q2
$4.93M Hold
40,000
0.01% 350
2020
Q1
$3.38M Hold
40,000
0.01% 373
2019
Q4
$3.38M Hold
40,000
0.01% 420
2019
Q3
$2.7M Hold
40,000
0.01% 433
2019
Q2
$3.43M Hold
40,000
0.01% 425
2019
Q1
$3.55M Buy
40,000
+10,000
+33% +$927K 0.01% 406
2018
Q4
$2.51M Buy
+30,000
New +$2.85M 0.01% 437
2018
Q3
Sell
-30,000
Closed -$2.83M 775
2018
Q2
$2.83M Sell
30,000
-75,200
-71% -$6.59M 0.01% 456
2018
Q1
$8.53M Buy
105,200
+75,200
+251% +$6.45M 0.03% 314
2017
Q4
$2.67M Buy
+30,000
New +$2.61M 0.01% 450

Other funds holding BMRN